Revenue | ₹3,290.88Cr |
Net Profits | ₹46.87Cr |
Net Profit Margins | 1.42% |
Glenmark Pharmaceuticals Ltd’s revenue jumped 0.46% since last year same period to ₹3,290.88Cr in the Q1 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 0.7% jump in its revenue since last 3-months.
Glenmark Pharmaceuticals Ltd’s net profit fell -86.23% since last year same period to ₹46.87Cr in the Q1 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 907.96% jump in its net profits since last 3-months.
Glenmark Pharmaceuticals Ltd’s net profit margin fell -86.29% since last year same period to 1.42% in the Q1 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 900.92% jumped in its net profit margins since last 3-months.
The revenue for Glenmark Pharmaceuticals Ltd in the Q1 results 2025 was ₹3,290.88Cr.
The net profit for Glenmark Pharmaceuticals Ltd in the Q1 results 2025 was ₹46.87Cr.
The net profit margin for Glenmark Pharmaceuticals Ltd in the Q1 results 2025 was 1.42%.
The revenue for Glenmark Pharmaceuticals Ltd in the Q1 results 2024 was ₹3,275.68Cr.
The net profit for Glenmark Pharmaceuticals Ltd in the Q1 results 2024 was ₹340.27Cr.
The net profit margin for Glenmark Pharmaceuticals Ltd in the Q1 results 2024 was 10.39%.